We are delighted to speak with Prof. Mariana Castells (Brigham and Women’s Hospital, Boston, MA) about Indolent Systemic Mastocytosis and Monoclonal Mast Cell Activation Syndrome.
The abstract entitled ‘A Phase 2/3 Study of BLU-263 in Patients with Indolent Systemic Mastocytosis or Monoclonal Mast Cell Activation Syndrome’ (Abstract #665) was presented at The American Academy of Allergy, Asthma & Immunology (AAAAI), February 25-28, 2022
Questions:
- Could you tell us a little about indolent systemic mastocytosis and monoclonal mast cell activation syndrome, and the unmet needs in their management? (00:25)
Disclosures: Mariana Castells has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.
Filmed in coverage of the virtual AAAAI 2022.
